JPEO-CBRND & BARDA Commercial Solutions Opening (CSO) Area of Interest (AoI) W911QY-20-S-C001-A004 SARS-CoV-2 Industrial Base Expansion (IBX)

Notice ID:

W911QY-20-S-C001-A004

Department/Ind. Agency:

DEPT OF DEFENSE

Sub-tier:

DEPT OF DEFENSE

Sub Command:

W6QK ACC-APG NATICK

Office:

W6QK ACC-APG NATICK

All Dates/Times are:

(utc-05:00) eastern standard time, new york, usa

Updated Published Date:

dec 17, 2021 04:42 pm est

Original Published Date:

0000-00-00 00:00:00

Original Response Date:

jul 15, 2021 06:00 am edt

Inactive Policy:

15 days after date offers due

Updated Inactive Date:

feb 01, 2022

Original Inactive Date:

jul 30, 2021

Initiative:

• None***--***

Product Service Code:

6515 - medical and surgical instruments, equipment, and supplies

NAICS Code:

325412 - pharmaceutical preparation manufacturing

Original Set Aside:

Under the President’s COVID-19 Countermeasures Acceleration Group, Health and Human Services is leading a whole of nation effort with the primary goal to execute on a well-defined portfolio of COVID-19 medical countermeasure (MCM) candidates to maximize probability of having safe and effective diagnostics, therapeutics, and vaccines as fast as possible for mass distributions. The current COVID-19 pandemic response exposed the limited availability of the consumables (and the raw materials to make them) that are required to manufacture COVID-19 MCM and the fragility of the global supply chain. Increasing the availability of these consumables, including the raw materials required to make them, within the continental US is critical to national security and ongoing domestic manufacturing of COVID-19 vaccines, therapeutics, and diagnostics. As such, The Biomedical Advanced Research and Development Authority (BARDA) has an Area of Interest (AoI) for innovative commercial products, technologies, or services that establish, expand, and/or accelerate domestic supply of consumables and domestic manufacturing capabilities related to MCMs.

10 GENERAL GREENE AVE

NATICK , MA 01760-5011

USA

Primary Point of Contacts:

Julia Wertley-Rotenberry

Secondary Point of Contact:

George Hunt